Organic compounds -- part of the class 532-570 series – Organic compounds – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2006-08-15
2006-08-15
Seaman, D. Margaret (Department: 1625)
Organic compounds -- part of the class 532-570 series
Organic compounds
Heterocyclic carbon compounds containing a hetero ring...
C546S006000, C546S010000, C546S088000, C549S206000, C549S210000, C549S212000, C514S185000, C514S184000, C514S186000, C514S187000, C514S188000, C514S492000
Reexamination Certificate
active
07091351
ABSTRACT:
The invention provides methods for treating cancer and compounds that are useful for the treatment of tumors, as well as pharmaceutical compositions comprising the compounds, and synthetic methods and intermediates useful for preparing the compounds.
REFERENCES:
patent: 4297341 (1981-10-01), Waller et al.
patent: 4322399 (1982-03-01), Ahmad et al.
patent: 4368186 (1983-01-01), Vickery et al.
patent: 4432967 (1984-02-01), Szymanski
patent: 4559157 (1985-12-01), Smith et al.
patent: 4588581 (1986-05-01), Schmolka
patent: 4608387 (1986-08-01), Kopf et al.
patent: 4608392 (1986-08-01), Jacquet et al.
patent: 4613497 (1986-09-01), Chavkin
patent: 4707362 (1987-11-01), Nuwayser
patent: 4795425 (1989-01-01), Pugh
patent: 4820508 (1989-04-01), Wortzman
patent: 4917901 (1990-04-01), Bourbon et al.
patent: 4938949 (1990-07-01), Borch et al.
patent: 4992478 (1991-02-01), Geria
patent: 4999342 (1991-03-01), Ahmad et al.
patent: 5013544 (1991-05-01), Chantler et al.
patent: 5021595 (1991-06-01), Datta
patent: 5069906 (1991-12-01), Cohen et al.
patent: 5300496 (1994-04-01), McNeill et al.
patent: 5387611 (1995-02-01), Rubinstein
patent: 5407919 (1995-04-01), Brode et al.
patent: 5512289 (1996-04-01), Tseng et al.
patent: 5595980 (1997-01-01), Brode et al.
patent: 5877210 (1999-03-01), Schieven
patent: 6051603 (2000-04-01), D'Cruz et al.
patent: 6245808 (2001-06-01), Uckun et al.
patent: 6432941 (2002-08-01), Uckun et al.
patent: 6743786 (2004-06-01), Uckun et al.
patent: 293 495 (1991-09-01), None
patent: 0 407 804 (1990-06-01), None
patent: WO 97/47296 (1997-12-01), None
Aistars, A. et al., 1997,Organometallics, vol. 16, pp. 1994-1996 Convenient Synthesis of Dichloro(oxo)(pentamethylcyclopentadienyl)vanadium(V), (η-C5Me5)V(O)Cl2.
Aitken, et al., 1989,Biol Reprod, 40:183-197 “Generation of Reactive Oxygen Species, Lipid Peroxidation and Human Sperm Function”.
Aitken, et al., 1993,J Reprod Fertil, 97:441-450 “Use of a Xanthine Oxidase Free Radical Generating System to Investigate the Cytotoxic Effects of Reactive Oxygen Species on Human Spermatozoa”.
Aitken, et al., 1994,Bio Essays, 16:259-267 “Reactive Oxygen Species Generation and Human Spermatozoa: The Balance of Benefit and Risk”.
Aitken, et al., 1995,Reprod. Fertil. Dev., 7:659-668 “Free Radicals, Lipid Peroxidation and Sperm Function”.
Albini, A. et al., 1987Cancer Research, vol. 47, pp. 3239-3245 (Jun. 15, 1987) “A Rapidin VitroAssay for Quantitating the Invasive Potential of Tumor Cells”.
Altamirano-Lozano, et al., 1996,Teratogenesis, Carcinogenesis, and Mutagenesis, 16:7-17 “Reprotoxic and Genotoxic Studies of Vanadium Pentoxide in Male Mice”.
Altamirano-Lozano, et al., 1997,Med. Sci. Rev., 25:147-150 “Effect of some metal compounds on sperm motility in vitro”.
Alvarez, et al., 1987,J Androl, 8:338-348 “Spontaneous Lipid Peroxidation and Production of Hydrogen Peroxide and Superoxide in Human Spermatozoa”.
Asami, S. et al., 1994,Cancer Res., 22:1774-1775 “Increase of a type of oxidative DNA damage, 8-hydroxyguanine, and its repair activity in human leukocytes by cigarette smoking”.
Asami, S. et al., 1996,Cancer Res., 56:2546-2549 “Increase of a type of oxidative DNA damage, 8-hydroxyguanine, and its repair activity in human leukocytes by cigarette smoking”.
Aubrecht, J. et al., 1999,Toxicology and Applied Pharmacology, vol. 154, No. 3, pp. 228-235 (Feb. 1, 1999) “Molecular Genotoxicity Profiles of Apoptosis-Inducing Vanadocene Complexes”.
Biggers et al., 1971,Methods in Mammalian Embryology, Daniel, JC Jr. (ed.), San Francisco: Freeman, pp. 86-116 “The Culture of Mouse Embryosin vitro”.
Bourinbaiar, et al., 1994,Life Sci, 54:PL 5-9 “Anti-HIV Effects of Gramicidinin vitro: Potential for Spermicidal Use”.
Burkman, L.J., 1991,Fertil Steril, 55:363-371 “Discrimination Between Nonhyperactivated and Classical Hyperactivated Motility Patterns in Human Spermatozoa Using Computerized Analysis”.
Butler A., et al., 1989,Inorganica Chimica Acta, 163:1-3 “Reactivation of Vanadate-Inhibited Enzymes with Deferoxamine B, a Vanadium (V) Chelator”.
Byczkowski, et al., 1988,Bull Environ Contam Toxicol, 41:696-703 “Vanadium-Mediated Lipid Peroxidation in Microsomes from Human Term Placenta”.
Carmichael A.J., 1990,FEBS Lett, 261:165-170 “Vanadyl-Induced Fenton Like Reaction in RNA: an ESR and Spin Trapping Study”.
Casey, A.T. et al., 1974,Aust. J. Chem, vol. 27, pp. 757-768 “Dithiochelates of the Bis(η-cyclopentadienyl)vanadium(IV) Moiety. IIN,N-Dialkyldithiocarbamate andO,O'-Dialkyldithiophosphate Complexes”.
Chen, D. et al., 1992,Bopuxue Zazhi, vol. 9 No. 1, pp. 25-44 “ESR studies on the oxovanadium phenanthroline complexes” (Abstract only).
Chen, D. et al., 1993,Chinese Journal of Magnetic Resonance, vol. 10, No. 3, pp. 287-294 (Sep. 1993) “Structure and ESR spectra of oxovanadium ternary complexes with aspartic acid and pi.-acceptor ligands”.
Chen, D. et al., 1993,Yingyong Huaxue, vol. 10, No. 3, pp. 68-71 “ESR Spectroscopic Study of Oxovanadium Complexes with His and π-Acceptor Ligands”.
Chen, D. et al., 1995,Chines Journal of Applied Chemistry, vol. 12, No. 2, pp. 59-62 (Apr. 1995) “Study on Structures and Spectra of Oxovanadium Complexes with Glu and Phen Ligands”.
Chen, D. et al., 1999,Journal of Magnetic Resonance, vol. 16, No. 1, pp. 53-58 (Feb. 1999) “Structures and spectra of VO(II)-Met-Phen complexes”.
Chou P., 1999,Photochemistry and Photobiology, vol. 70, No. 5, pp- 745-750 “Direct Spectroscopic Evidence for 1ΔgO2Production from the Photolysis of Vanadium(V)-Peroxo Complexes in Adqeous Solution”.
Choukroun, R. et al., 1995,Organometallics, vol. 14, pp. 4471-4473 “Redox Properties of Cationic Vanadium (IV): [Cp2VCH3(CH3CN)] [BPh4]”.
Cossarizza, A. et al., 1993,Biochem. Biophys. Res. Comm., 197:40-45 A new method for the cytofluorometric analysis of mitochondrial membrane potential using the J-aggregate forming lipophilic cations 5,5′ , 6,6′-tetrachloro-1,1′,3,3′-tetraethylbenzimidazolcarbocyanine.
D'Cruz, et al., 1995,Biol Reprod, 53: 1118-1130 “β2-Integrin (CD11b/CD18) is the Primary Adhesive Glycoprotein Complex Involved in Neutrophil-Mediated Immune Injury to Human Sperm”.
D'Cruz et al., “Spermicidal Activity of Oxovanadium(IV) Complexes of 1,10-Phenanthroline, 2,2′-Bipyridyl, 5′-Bromo-2′-Hydroxyacetophenone and Derivatives in Humans”,Biology of Reproduction, vol. 60, No. 2, pp. 435-444 (Feb. 1999).
D'Cruz, O. et al., 1998,Biol. Reprod., 58:1515-1526 &Chemical Abstracts, 129, Abstract No. 76657x:1page “Spermicidal activity of metallocene complexes containing vanadium(IV) in humans”.
D'Cruz, O. et al., “Spermicidal activity of oxovanadium(IV) complexes of 1,10-phenanthroline, 2,2′-bipyridyl, 5′-bromo-2′-hydroxyacetophenone and derivatives in humans”,Chemical Abstracts, vol. 130, Abstract No. 262258, 1 page (Copyright 1999).
D'Cruz, O.J. et al., 1992,Fertil. Steril., 58:633-636 “Flow cytometric quantitation of the expression of membrane cofactor protein as a marker for the human sperm acrosome reaction”.
D'Cruz, O.J. et al., 1993,Fertil. Steril., 59:876-884 “The expression of complement regulators CD46, CD55, and CD59 by human sperm does not protect them from antisperm antibody- and complement-mediated injury”.
D'Cruz, O.J. et al., 1996,Biol. Reprod., 54:1217-1228 “Recombinant soluble human complement receptor type 1 inhibits antisperm antibody-and neutrophil-mediated injury to human sperm”.
D'Cruz, O.J. et al., 1998,Adv. Reprod., 1:102-123 “Vandocenes as a new class of effective spermicides”.
D'Cruz, O.J. et al., 1998,Biol. Reprod.58:1515-1526 “Spermicidal activity of metal
Dong Yanhong
Gosh Phalguni
Uckun Fatih M.
Merchant & Gould P.C.
Parker Hughes Institute
Seaman D. Margaret
LandOfFree
Vanadium compounds for treating cancer does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Vanadium compounds for treating cancer, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Vanadium compounds for treating cancer will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3636626